138 related articles for article (PubMed ID: 9171269)
1. Status of lung transplant recipients surviving beyond five years.
Chaparro C; Scavuzzo M; Winton T; Keshavjee S; Kesten S
J Heart Lung Transplant; 1997 May; 16(5):511-6. PubMed ID: 9171269
[TBL] [Abstract][Full Text] [Related]
2. Analysis of lung transplant recipients surviving beyond 5 years.
Lama R; Santos F; Alvarez A; Algar FJ; Baamonde C; Quero F; Cerezo F; Salvatierra A
Transplant Proc; 2005 Apr; 37(3):1523-5. PubMed ID: 15866662
[TBL] [Abstract][Full Text] [Related]
3. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.
Valentine VG; Robbins RC; Berry GJ; Patel HR; Reichenspurner H; Reitz BA; Theodore J
J Heart Lung Transplant; 1996 Apr; 15(4):371-83. PubMed ID: 8732596
[TBL] [Abstract][Full Text] [Related]
4. Primary graft dysfunction and long-term pulmonary function after lung transplantation.
Whitson BA; Prekker ME; Herrington CS; Whelan TP; Radosevich DM; Hertz MI; Dahlberg PS
J Heart Lung Transplant; 2007 Oct; 26(10):1004-11. PubMed ID: 17919620
[TBL] [Abstract][Full Text] [Related]
5. Long-term pulmonary function after living-donor lobar lung transplantation in adults.
Bowdish ME; Pessotto R; Barbers RG; Schenkel FA; Starnes VA; Barr ML
Ann Thorac Surg; 2005 Feb; 79(2):418-25. PubMed ID: 15680807
[TBL] [Abstract][Full Text] [Related]
6. Causes of death in lung transplant recipients.
Chaparro C; Maurer JR; Chamberlain D; De Hoyos A; Winton T; Westney G; Kesten S
J Heart Lung Transplant; 1994; 13(5):758-66. PubMed ID: 7803415
[TBL] [Abstract][Full Text] [Related]
7. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
[TBL] [Abstract][Full Text] [Related]
8. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.
Davis RD; Lau CL; Eubanks S; Messier RH; Hadjiliadis D; Steele MP; Palmer SM
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):533-42. PubMed ID: 12658195
[TBL] [Abstract][Full Text] [Related]
9. Lower incidence of bronchiolitis obliterans in pediatric liver-lung transplant recipients with cystic fibrosis.
Faro A; Shepherd R; Huddleston CB; Lowell J; Gandhi S; Nadler M; Sweet SC
Transplantation; 2007 Jun; 83(11):1435-9. PubMed ID: 17565316
[TBL] [Abstract][Full Text] [Related]
10. Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients.
Hohlfeld J; Niedermeyer J; Hamm H; Schäfers HJ; Wagner TO; Fabel H
J Heart Lung Transplant; 1996 Sep; 15(9):888-94. PubMed ID: 8889984
[TBL] [Abstract][Full Text] [Related]
11. Lung transplantation in patients with cystic fibrosis: the Israeli experience.
Prais D; Raviv Y; Shitrit D; Yellin A; Sahar G; Bendayan D; Yahav Y; Efrati O; Reichart N; Blau H; Bakal I; Buchman G; Saute M; Vidne B; Kramer MR
Isr Med Assoc J; 2006 Jun; 8(6):396-9. PubMed ID: 16833168
[TBL] [Abstract][Full Text] [Related]
12. Lung transplantation for cystic fibrosis: 6-year follow-up.
Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome after pulmonary retransplantation.
Strueber M; Fischer S; Gottlieb J; Simon AR; Goerler H; Gohrbandt B; Welte T; Haverich A
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):407-12. PubMed ID: 16872970
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
[TBL] [Abstract][Full Text] [Related]
15. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
[TBL] [Abstract][Full Text] [Related]
16. Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation.
Munster JM; van der Bij W; Breukink MB; van der Steege G; Zuurman MW; Hepkema BG; Verschuuren EA; van Son WJ; Seelen MA
Transplantation; 2008 Dec; 86(12):1857-63. PubMed ID: 19104434
[TBL] [Abstract][Full Text] [Related]
17. [Survival and impact of bronchiolitis obliterans syndrome after lung transplantation at the Academic Hospital Groningen, 1990/'98].
van den Berg JW; van der Bij W; de Boer WJ; Postma DS; Timens W; Koëter GH
Ned Tijdschr Geneeskd; 1999 Oct; 143(44):2196-201. PubMed ID: 10578412
[TBL] [Abstract][Full Text] [Related]
18. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
[TBL] [Abstract][Full Text] [Related]
19. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of lung transplantation for cystic fibrosis--Danish results.
Bech B; Pressler T; Iversen M; Carlsen J; Milman N; Eliasen K; Perko M; Arendrup H
Eur J Cardiothorac Surg; 2004 Dec; 26(6):1180-6. PubMed ID: 15541981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
